Evaluation of the Nocebo Effect after Switching from Etanercept or Adalimumab Originator to a Biosimilar: a Retrospective Study of Patients with Inflammatory Rheumatism.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY（2025）
Key words
biologic DMARD,rheumatoid arthritis,spondyloarthritis,biosimilar,nocebo
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined